{"transactions":[{"id":4636247,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T20:42:08.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":8680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of fully vested restricted stock units."}],"balance_after":5863480,"source":{"system":"sec-edgar","filing":"0001480212-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000148021226000010/primarydocument.xml","form_type":"4"}},{"id":673514,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":18980,"kind":"person","name":"PATEL DHAVALKUMAR DHIRAJLAL","position":1,"cik":"0002115339","reported_name":"PATEL DHAVALKUMAR DHIRAJLAL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-27T20:21:33.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of August 26, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of August 26, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of August 26, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of August 26, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":250000,"derivative":{"underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0002115339-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000211533926000004/primarydocument.xml","form_type":"4"}},{"id":673513,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":18980,"kind":"person","name":"PATEL DHAVALKUMAR DHIRAJLAL","position":1,"cik":"0002115339","reported_name":"PATEL DHAVALKUMAR DHIRAJLAL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-27T20:21:33.000Z","date":"2026-08-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":41158,"price":4.11,"value":169159.38,"ownership":{"direct":true},"balance_after":183352,"source":{"system":"sec-edgar","filing":"0002115339-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000211533926000004/primarydocument.xml","form_type":"4"}},{"id":673512,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":18980,"kind":"person","name":"PATEL DHAVALKUMAR DHIRAJLAL","position":1,"cik":"0002115339","reported_name":"PATEL DHAVALKUMAR DHIRAJLAL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-27T20:21:33.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":224510,"source":{"system":"sec-edgar","filing":"0002115339-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000211533926000004/primarydocument.xml","form_type":"4"}},{"id":713594,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T20:31:18.000Z","date":"2026-07-06","kind":"grant","planned":false,"acquired":true,"shares":6297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of fully vested restricted stock units."}],"balance_after":5854800,"source":{"system":"sec-edgar","filing":"0001480212-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000148021226000008/primarydocument.xml","form_type":"4"}},{"id":747669,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40863,"kind":"person","name":"Yang Patrick Y","position":1,"cik":"0001309988","reported_name":"Yang Patrick Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:43:34.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001309988-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309988/000130998826000002/primarydocument.xml","form_type":"4"}},{"id":747459,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:41:26.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001645041-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645041/000164504126000002/primarydocument.xml","form_type":"4"}},{"id":747405,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:39:59.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001836301-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000183630126000014/primarydocument.xml","form_type":"4"}},{"id":747417,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":35891,"kind":"person","name":"REICIN ALISE","position":1,"cik":"0001757533","reported_name":"REICIN ALISE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:38:16.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001757533-26-000011","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757533/000175753326000011/primarydocument.xml","form_type":"4"}},{"id":747599,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:36:53.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001376247-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000137624726000002/primarydocument.xml","form_type":"4"}},{"id":747841,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:34:54.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001480212-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000148021226000006/primarydocument.xml","form_type":"4"}},{"id":747882,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40911,"kind":"person","name":"Bilenker Joshua H.","position":1,"cik":"0001612312","reported_name":"Bilenker Joshua H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:32:49.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001612312-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612312/000161231226000002/primarydocument.xml","form_type":"4"}},{"id":747685,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":1,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:25:27.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date"}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001770121-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219042/000177012126000003/primary_doc.xml","form_type":"4"}},{"id":812493,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-08T20:16:24.000Z","date":"2026-04-06","kind":"grant","planned":false,"acquired":true,"shares":7763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of fully vested restricted stock units."}],"balance_after":5848503,"source":{"system":"sec-edgar","filing":"0001480212-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000148021226000004/primarydocument.xml","form_type":"4"}},{"id":850252,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T16:16:12.000Z","date":"2026-03-07","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vested as to 25% of the restricted stock units on each of March 7, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of March 7, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The award vested as to 25% of the restricted stock units on each of March 7, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of March 7, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001627387-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000162738726000004/primarydocument.xml","form_type":"4"}},{"id":850251,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T16:16:12.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":41666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested as to 25% of the restricted stock units on March 6, 2026, and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The award vested as to 25% of the restricted stock units on March 6, 2026, and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":125001,"derivative":{"underlying":"Common Stock","underlying_shares":41666},"source":{"system":"sec-edgar","filing":"0001627387-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000162738726000004/primarydocument.xml","form_type":"4"}},{"id":850250,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-10T16:16:12.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":12819,"price":3.1,"value":39738.9,"ownership":{"direct":true},"balance_after":7944251,"source":{"system":"sec-edgar","filing":"0001627387-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000162738726000004/primarydocument.xml","form_type":"4"}},{"id":850249,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-10T16:16:12.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":11526,"price":3.13,"value":36076.38,"ownership":{"direct":true},"balance_after":7957070,"source":{"system":"sec-edgar","filing":"0001627387-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000162738726000004/primarydocument.xml","form_type":"4"}},{"id":850248,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-10T16:16:12.000Z","date":"2026-03-07","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7968596,"source":{"system":"sec-edgar","filing":"0001627387-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000162738726000004/primarydocument.xml","form_type":"4"}},{"id":850247,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-10T16:16:12.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":41666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7918596,"source":{"system":"sec-edgar","filing":"0001627387-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000162738726000004/primarydocument.xml","form_type":"4"}},{"id":850388,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-07","kind":"exercise","planned":false,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested as to 25% of the restricted stock units on each of March 7, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of March 7, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The award vested as to 25% of the restricted stock units on each of March 7, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of March 7, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":6500,"derivative":{"underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850387,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":10416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on March 6, 2026, and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on March 6, 2026, and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":31251,"derivative":{"underlying":"Common Stock","underlying_shares":10416},"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850386,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1045,"price":3.1,"value":3239.5,"ownership":{"direct":true},"balance_after":196196,"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850385,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":3342,"price":3.13,"value":10460.46,"ownership":{"direct":true},"balance_after":197241,"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850384,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-07","kind":"exercise","planned":false,"acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200583,"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850383,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":10416,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":197333,"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":855494,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T16:53:37.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":206250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 5, 2027 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":206250,"derivative":{"exercise_price":3.41,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":206250},"source":{"system":"sec-edgar","filing":"0001568605-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000006/primarydocument.xml","form_type":"4"}},{"id":855493,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-06T16:53:37.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":45833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 5, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 5, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":45833,"derivative":{"underlying":"Common Stock","underlying_shares":45833},"source":{"system":"sec-edgar","filing":"0001568605-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000006/primarydocument.xml","form_type":"4"}},{"id":855445,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T16:52:46.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 5, 2027 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":900000,"derivative":{"exercise_price":3.41,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001627387-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000162738726000002/primarydocument.xml","form_type":"4"}},{"id":855444,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-06T16:52:46.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 5, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 5, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":200000,"derivative":{"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001627387-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000162738726000002/primarydocument.xml","form_type":"4"}},{"id":860746,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T16:17:38.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of March 2, 2024, 2025 and 2026, and the remaining restricted stock units will vest on March 2, 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of March 2, 2024, 2025 and 2026, and the remaining restricted stock units will vest on March 2, 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":1525,"derivative":{"underlying":"Common Stock","underlying_shares":1525},"source":{"system":"sec-edgar","filing":"0001568605-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000004/primarydocument.xml","form_type":"4"}},{"id":860745,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T16:17:38.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":491,"price":3.91,"value":1919.81,"ownership":{"direct":true},"balance_after":186917,"source":{"system":"sec-edgar","filing":"0001568605-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000004/primarydocument.xml","form_type":"4"}},{"id":860744,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T16:17:38.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":true,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":187408,"source":{"system":"sec-edgar","filing":"0001568605-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000004/primarydocument.xml","form_type":"4"}},{"id":896813,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":65899,"kind":"person","name":"Piper Brian","position":1,"cik":"0001665924","reported_name":"Piper Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-18T16:35:39.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the underlying shares on February 17, 2027 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":900000,"derivative":{"exercise_price":3.85,"expiration_date":"2036-02-16","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001665924-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665924/000166592426000008/primarydocument.xml","form_type":"4"}},{"id":896812,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":65899,"kind":"person","name":"Piper Brian","position":1,"cik":"0001665924","reported_name":"Piper Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T16:35:39.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of February 17, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of February 17, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":200000,"derivative":{"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001665924-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665924/000166592426000008/primarydocument.xml","form_type":"4"}},{"id":946631,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:18:55.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":6157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of fully vested restricted stock units."}],"balance_after":5840740,"source":{"system":"sec-edgar","filing":"0001480212-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000148021226000002/primarydocument.xml","form_type":"4"}},{"id":945742,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-01-06T16:18:40.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 40% of the restricted stock units on January 2, 2025 and 60% of the restricted stock units on January 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 40% of the restricted stock units on January 2, 2025 and 60% of the restricted stock units on January 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001568605-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000002/primarydocument.xml","form_type":"4"}},{"id":945741,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T16:18:40.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2407,"price":4.27,"value":10277.89,"ownership":{"direct":true},"balance_after":185883,"source":{"system":"sec-edgar","filing":"0001568605-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000002/primarydocument.xml","form_type":"4"}},{"id":945740,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T16:18:40.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":188290,"source":{"system":"sec-edgar","filing":"0001568605-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000002/primarydocument.xml","form_type":"4"}},{"id":967095,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-16T16:16:41.000Z","date":"2025-12-13","kind":"exercise","planned":false,"acquired":false,"shares":3400,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 100% of the restricted stock units on December 13, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 100% of the restricted stock units on December 13, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001568605-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000007/primarydocument.xml","form_type":"4"}},{"id":967094,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-16T16:16:41.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":873,"price":5.22,"value":4557.06,"ownership":{"direct":true},"balance_after":180790,"source":{"system":"sec-edgar","filing":"0001568605-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000007/primarydocument.xml","form_type":"4"}},{"id":967093,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-16T16:16:41.000Z","date":"2025-12-13","kind":"exercise","planned":false,"acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":181663,"source":{"system":"sec-edgar","filing":"0001568605-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000007/primarydocument.xml","form_type":"4"}},{"id":978755,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-05T17:04:09.000Z","date":"2025-12-03","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978754,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-05T17:04:09.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978753,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-05T17:04:09.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 100% of the shares underlying the option on January 13, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":5100,"derivative":{"exercise_price":1.89,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":5100},"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978752,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-05T17:04:09.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The award vests as to 100% of the restricted stock units on December 13, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The award vests as to 100% of the restricted stock units on December 13, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":3400,"derivative":{"underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978751,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-05T17:04:09.000Z","date":"2025-12-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2565,"price":4.44,"value":11388.6,"ownership":{"direct":true},"balance_after":178263,"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978750,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-05T17:04:09.000Z","date":"2025-12-03","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,000 shares acquired on November 14, 2025 pursuant to the ESPP."}],"balance_after":180828,"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978749,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-05T17:04:09.000Z","date":"2025-06-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2567,"price":2.32,"value":5955.44,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."}],"balance_after":167828,"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978748,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-05T17:04:09.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,000 shares acquired on May 15, 2025 pursuant to Sana Biotechnology, Inc.'s (\"Sana\") 2021 Employee Stock Purchase Plan (the \"ESPP\")."}],"balance_after":170395,"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":1022136,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T21:21:43.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":5628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of fully vested restricted stock units."}],"balance_after":5834583,"source":{"system":"sec-edgar","filing":"0001480212-25-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000148021225000006/primarydocument.xml","form_type":"4"}},{"id":1090578,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-08T20:17:31.000Z","date":"2025-07-07","kind":"grant","planned":false,"acquired":true,"shares":7842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of fully vested restricted stock units."}],"balance_after":5828955,"source":{"system":"sec-edgar","filing":"0001562180-25-005349","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000156218025005349/primarydocument.xml","form_type":"4"}},{"id":1117352,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":30935,"kind":"person","name":"Rosiello Robert L.","position":1,"cik":"0001645041","reported_name":"Rosiello Robert L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:40:33.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 36 equal monthly installments beginning on July 5, 2025, provided that the reporting person provides continuous service to Sana Biotechnology, Inc. through each such date."}],"balance_after":115000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001562180-25-004647","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645041/000156218025004647/primarydocument.xml","form_type":"4"}},{"id":1117851,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40911,"kind":"person","name":"Bilenker Joshua H.","position":1,"cik":"0001612312","reported_name":"Bilenker Joshua H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:40:28.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004646","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612312/000156218025004646/primarydocument.xml","form_type":"4"}},{"id":1117831,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:40:10.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004645","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000156218025004645/primarydocument.xml","form_type":"4"}},{"id":1117525,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:40:01.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004644","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218025004644/primarydocument.xml","form_type":"4"}},{"id":1117318,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":35891,"kind":"person","name":"REICIN ALISE","position":1,"cik":"0001757533","reported_name":"REICIN ALISE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:39:32.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004643","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757533/000156218025004643/primarydocument.xml","form_type":"4"}},{"id":1117580,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":1,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:39:21.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004642","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219042/000156218025004642/primarydocument.xml","form_type":"4"}},{"id":1117317,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:39:07.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004641","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218025004641/primarydocument.xml","form_type":"4"}},{"id":1118260,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":2258,"kind":"person","name":"Wilderotter Mary Agnes","position":1,"cik":"0001180610","reported_name":"Wilderotter Mary Agnes","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:38:58.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004640","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180610/000156218025004640/primarydocument.xml","form_type":"4"}},{"id":1117556,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40863,"kind":"person","name":"Yang Patrick Y","position":1,"cik":"0001309988","reported_name":"Yang Patrick Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:38:41.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004639","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309988/000156218025004639/primarydocument.xml","form_type":"4"}},{"id":1175426,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-08T20:22:32.000Z","date":"2025-04-07","kind":"grant","planned":false,"acquired":true,"shares":16339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of fully vested restricted stock units."}],"balance_after":5821113,"source":{"system":"sec-edgar","filing":"0001562180-25-003066","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000156218025003066/primarydocument.xml","form_type":"4"}},{"id":1214519,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":9750,"derivative":{"underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1214518,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":187500,"derivative":{"exercise_price":2.55,"expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1214517,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":41667,"derivative":{"underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1214516,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":836,"price":2.56,"value":2140.16,"ownership":{"direct":true},"balance_after":157395,"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1214515,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158231,"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1214640,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":82192,"kind":"person","name":"Cassidy Bernard J","position":1,"cik":"0001398322","reported_name":"Cassidy Bernard J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T20:12:58.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":11041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":33126,"derivative":{"underlying":"Common Stock","underlying_shares":11041},"source":{"system":"sec-edgar","filing":"0001562180-25-002273","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1398322/000156218025002273/primarydocument.xml","form_type":"4"}},{"id":1214639,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":82192,"kind":"person","name":"Cassidy Bernard J","position":1,"cik":"0001398322","reported_name":"Cassidy Bernard J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-10T20:12:58.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":240000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001562180-25-002273","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398322/000156218025002273/primarydocument.xml","form_type":"4"}},{"id":1214638,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":82192,"kind":"person","name":"Cassidy Bernard J","position":1,"cik":"0001398322","reported_name":"Cassidy Bernard J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T20:12:58.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":53333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":53333,"derivative":{"underlying":"Common Stock","underlying_shares":53333},"source":{"system":"sec-edgar","filing":"0001562180-25-002273","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398322/000156218025002273/primarydocument.xml","form_type":"4"}},{"id":1214637,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":82192,"kind":"person","name":"Cassidy Bernard J","position":1,"cik":"0001398322","reported_name":"Cassidy Bernard J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-03-10T20:12:58.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2833,"price":2.56,"value":7252.48,"ownership":{"direct":true},"balance_after":112990,"source":{"system":"sec-edgar","filing":"0001562180-25-002273","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398322/000156218025002273/primarydocument.xml","form_type":"4"}},{"id":1214636,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":82192,"kind":"person","name":"Cassidy Bernard J","position":1,"cik":"0001398322","reported_name":"Cassidy Bernard J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-03-10T20:12:58.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":11041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,001 shares acquired on May 15, 2023 and 3,000 shares acquired on each of November 15, 2023, May 15, 2024 and November 15, 2024, in each case, pursuant to Sana Biotechnology, Inc.'s (\"Sana\") 2021 Employee Stock Purchase Plan."}],"balance_after":115823,"source":{"system":"sec-edgar","filing":"0001562180-25-002273","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398322/000156218025002273/primarydocument.xml","form_type":"4"}},{"id":1214451,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T20:12:47.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001562180-25-002271","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000156218025002271/primarydocument.xml","form_type":"4"}},{"id":1214450,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-10T20:12:47.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":750000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001562180-25-002271","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000156218025002271/primarydocument.xml","form_type":"4"}},{"id":1214449,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T20:12:47.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":166667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":166667,"derivative":{"underlying":"Common Stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001562180-25-002271","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000156218025002271/primarydocument.xml","form_type":"4"}},{"id":1214448,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-10T20:12:47.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":12820,"price":2.56,"value":32819.2,"ownership":{"direct":true},"balance_after":7876930,"source":{"system":"sec-edgar","filing":"0001562180-25-002271","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000156218025002271/primarydocument.xml","form_type":"4"}},{"id":1214447,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61688,"kind":"person","name":"Harr Steve","position":1,"cik":"0001627387","reported_name":"Harr Steve","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-10T20:12:47.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7889750,"source":{"system":"sec-edgar","filing":"0001562180-25-002271","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627387/000156218025002271/primarydocument.xml","form_type":"4"}},{"id":1235222,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-03-03T19:28:58.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":false,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of March 2, 2024 and 2025, and the remaining restricted stock units vest in two equal installments on each of March 2, 2026 and 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of March 2, 2024 and 2025, and the remaining restricted stock units vest in two equal installments on each of March 2, 2026 and 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":3050,"derivative":{"underlying":"Common Stock","underlying_shares":1525},"source":{"system":"sec-edgar","filing":"0001562180-25-001888","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025001888/primarydocument.xml","form_type":"4"}},{"id":1235221,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-03T19:28:58.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":490,"price":2.56,"value":1254.4,"ownership":{"direct":true},"balance_after":154981,"source":{"system":"sec-edgar","filing":"0001562180-25-001888","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025001888/primarydocument.xml","form_type":"4"}},{"id":1235220,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-03T19:28:58.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":true,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":155471,"source":{"system":"sec-edgar","filing":"0001562180-25-001888","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025001888/primarydocument.xml","form_type":"4"}},{"id":1306119,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"Common Stock","published_at":"2025-01-10T18:32:59.000Z","date":"2025-01-08","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":7.26,"value":7260.0,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"balance_after":4541511,"source":{"system":"sec-edgar","filing":"0000950170-25-004052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/315066/000095017025004052/ownership.xml","form_type":"4"}},{"id":1306118,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"Common Stock","published_at":"2025-01-10T18:32:59.000Z","date":"2025-01-08","kind":"sale","planned":false,"acquired":false,"shares":164912,"price":6.71,"value":1106559.52,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $6.20 to $6.98. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4542511,"source":{"system":"sec-edgar","filing":"0000950170-25-004052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/315066/000095017025004052/ownership.xml","form_type":"4"}},{"id":1306117,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"Common Stock","published_at":"2025-01-10T18:32:59.000Z","date":"2025-01-08","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":6.5,"value":162500.0,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $6.50 to $6.55. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4707423,"source":{"system":"sec-edgar","filing":"0000950170-25-004052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/315066/000095017025004052/ownership.xml","form_type":"4"}},{"id":1306116,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"Common Stock","published_at":"2025-01-10T18:32:59.000Z","date":"2025-01-08","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":6.11,"value":611000.0,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $6.05 to $6.24. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4732423,"source":{"system":"sec-edgar","filing":"0000950170-25-004052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/315066/000095017025004052/ownership.xml","form_type":"4"}},{"id":1307948,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-07T21:26:29.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":14285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of fully vested restricted stock units."}],"balance_after":5804774,"source":{"system":"sec-edgar","filing":"0001562180-25-000238","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000156218025000238/primarydocument.xml","form_type":"4"}},{"id":1313608,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-01-03T16:15:57.000Z","date":"2025-01-02","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested as to 40% of the restricted stock units on January 2, 2025 and the remaining 60% of the restricted stock units will vest on January 2, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The award vested as to 40% of the restricted stock units on January 2, 2025 and the remaining 60% of the restricted stock units will vest on January 2, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-25-000105","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025000105/primarydocument.xml","form_type":"4"}},{"id":1313607,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-03T16:15:57.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1566,"price":1.65,"value":2583.9,"ownership":{"direct":true},"balance_after":153946,"source":{"system":"sec-edgar","filing":"0001562180-25-000105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025000105/primarydocument.xml","form_type":"4"}},{"id":1313606,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-03T16:15:57.000Z","date":"2025-01-02","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,000 shares acquired on November 15, 2024 pursuant to Sana Biotechnology, Inc.'s (\"Sana\") 2021 Employee Stock Purchase Plan."}],"balance_after":155512,"source":{"system":"sec-edgar","filing":"0001562180-25-000105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025000105/primarydocument.xml","form_type":"4"}},{"id":1388603,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-09T20:11:06.000Z","date":"2024-10-07","kind":"grant","planned":false,"acquired":true,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of fully vested restricted stock units."}],"balance_after":5790489,"source":{"system":"sec-edgar","filing":"0001562180-24-007283","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000156218024007283/primarydocument.xml","form_type":"4"}},{"id":1398884,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-26T20:07:23.000Z","date":"2024-09-25","kind":"sale","planned":true,"acquired":false,"shares":150000,"price":3.8878,"value":583170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.69 to $4.13, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2698121,"source":{"system":"sec-edgar","filing":"0001562180-24-006954","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218024006954/primarydocument.xml","form_type":"4"}},{"id":1398883,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-26T20:07:23.000Z","date":"2024-09-24","kind":"sale","planned":true,"acquired":false,"shares":150000,"price":4.0838,"value":612570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.16, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2848121,"source":{"system":"sec-edgar","filing":"0001562180-24-006954","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218024006954/primarydocument.xml","form_type":"4"}},{"id":1454465,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40863,"kind":"person","name":"Yang Patrick Y","position":1,"cik":"0001309988","reported_name":"Yang Patrick Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:13:39.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005724","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309988/000156218024005724/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1454446,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:13:09.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005723","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218024005723/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1454469,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":1,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:12:50.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005722","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219042/000156218024005722/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1454710,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":2258,"kind":"person","name":"Wilderotter Mary Agnes","position":1,"cik":"0001180610","reported_name":"Wilderotter Mary Agnes","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:12:36.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005721","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180610/000156218024005721/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1454383,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:12:16.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005720","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218024005720/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1454388,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":35891,"kind":"person","name":"REICIN ALISE","position":1,"cik":"0001757533","reported_name":"REICIN ALISE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:11:56.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005719","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757533/000156218024005719/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1454545,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":35372,"kind":"person","name":"Cole Douglas G.","position":1,"cik":"0001486373","reported_name":"Cole Douglas G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:11:44.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005718","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1486373/000156218024005718/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1454544,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":31685,"kind":"person","name":"Bishop Hans Edgar","position":1,"cik":"0001480212","reported_name":"Bishop Hans Edgar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:09:15.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005716","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1480212/000156218024005716/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1454565,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40911,"kind":"person","name":"Bilenker Joshua H.","position":1,"cik":"0001612312","reported_name":"Bilenker Joshua H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:08:55.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005715","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612312/000156218024005715/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}}],"next_cursor":"2024-07-15T20:08:55.000000Z,1454565"}